Related case:
ADDPI 2022_244 INADA vs Amandeep
February 3, 2023
On 3 February 2023 the Anti-Doping Disciplinary Panel of India (ADDPI) decided to impose a 4 year period of ineligibility on the Athlete Amandeep after his sample tested positive for the prohibited substance Darbepoetin (dEPO). Hereafter the Athlete appealed the ADDPI Decision with the Anti-Doping Appeal Panel of India (ADAPI).
The Athlete accepted the test result and denied the intentional use of the substance. He stated that he had received "dope free" injections for muscle relaxation and recovery on advice of his coach.
INADA contended that Athlete had acted negligently while he previously had followed multiple anti-doping awareness programmes. In spite of all that he did not consult a doctor about these injections nor did he check the substance.
The Appeal Panel assessed the Athlete's conduct in this case and agrees that the Athlete had acted with significant fault in accepting these injections from his coach. The Panel concludes that there are no grounds for a reduced sanction.
Therefore the Appeal Panel decides on 20 Oktober 2023 to dismiss the Athlete's appeal and to uphold the Appealed Decision of 3 February 2023.
